Bliss Gvs Pharma Limited Financial Overview
Bliss Gvs Pharma Limited's market cap is currently ₹17.61B. The company's EPS TTM is ₹2.58; its P/E ratio is 16.03; and it has a dividend yield of 0.28%. Bliss Gvs Pharma Limited is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
